Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Farb

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Journal of Cardiovascular Computed Tomography|August 31, 2010
From histology to computed tomography: every picture tells a storyAndrew Farb
Journal of Vascular Surgery|March 1, 2013
Application of Investigational Device Exemptions regulations to endograft modificationDorothy Abel, Andrew Farb
JACC. Cardiovascular Interventions|February 25, 2012
Live case demonstration of interventional cardiology procedures: a regulatory perspectiveAndrew Farb, Bram Zuckerman
The New England Journal of Medicine|February 14, 2007
Stent thrombosis redux--the FDA perspectiveAndrew Farb, Ashley B Boam
American Heart Journal|September 11, 2017
Clinical event adjudication in cardiovascular device trials: An Food and Drug Administration perspectiveAndrew Farb, Bram D Zuckerman
Journal of Cardiovascular Electrophysiology|February 22, 2023
Early feasibility studies in the United States: Focus on electrophysiologyJ Peter Weiss, Andrew Farb
Polskie Archiwum Medycyny Wewnetrznej|August 22, 2009
Severe coronary artery disease: is there a place for percutaneous coronary intervention?William R Herzog, Andrew Farb
Journal of Vascular and Interventional Radiology : JVIR|August 27, 2017
First Device to Market: Highlighting the Value of the US Early Feasibility Study ProgramJose Pablo Morales, Andrew Farb
International Journal of Cardiovascular Interventions|March 8, 2003
Images in Cardiology PTCA for in-stent restenosis: poor outcome explainedAndrew Farb, Augusto Pichard, Renu Virmani
JAMA Cardiology|February 2, 2022
Noninferiority Margins in Clinical Trials-A Moving Target?Li Wang, Rebecca Torguson, Andrew Farb
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Computed Tomography|August 31, 2010
From histology to computed tomography: every picture tells a storyAndrew Farb
Journal of Vascular Surgery|March 1, 2013
Application of Investigational Device Exemptions regulations to endograft modificationDorothy Abel, Andrew Farb
JACC. Cardiovascular Interventions|February 25, 2012
Live case demonstration of interventional cardiology procedures: a regulatory perspectiveAndrew Farb, Bram Zuckerman
The New England Journal of Medicine|February 14, 2007
Stent thrombosis redux--the FDA perspectiveAndrew Farb, Ashley B Boam
American Heart Journal|September 11, 2017
Clinical event adjudication in cardiovascular device trials: An Food and Drug Administration perspectiveAndrew Farb, Bram D Zuckerman
Journal of Cardiovascular Electrophysiology|February 22, 2023
Early feasibility studies in the United States: Focus on electrophysiologyJ Peter Weiss, Andrew Farb
Polskie Archiwum Medycyny Wewnetrznej|August 22, 2009
Severe coronary artery disease: is there a place for percutaneous coronary intervention?William R Herzog, Andrew Farb
Journal of Vascular and Interventional Radiology : JVIR|August 27, 2017
First Device to Market: Highlighting the Value of the US Early Feasibility Study ProgramJose Pablo Morales, Andrew Farb
International Journal of Cardiovascular Interventions|March 8, 2003
Images in Cardiology PTCA for in-stent restenosis: poor outcome explainedAndrew Farb, Augusto Pichard, Renu Virmani
JAMA Cardiology|February 2, 2022
Noninferiority Margins in Clinical Trials-A Moving Target?Li Wang, Rebecca Torguson, Andrew Farb
Pageof 10